Artillegence Bio-Innovations Ltd vs Kotak Mahindra Bank Limited
A side-by-side comparison of Artillegence Bio-Innovations Ltd (512642) and Kotak Mahindra Bank Limited (KOTAKBANK) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Kotak Mahindra Bank Limited leads 512642 vs KOTAKBANK on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth01
- Size & financial health03
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
KOTAKBANK takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
KOTAKBANK takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
KOTAKBANK takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Stock is trading at 0.10 times its book value"]
- − ["The company has delivered a poor sales growth of -27.2% over past five years.", "Company has a low return on equity of -0.35% over last 3 years.", "Company has high debtors of 260 days.", "Working capital days have increased from 1,486 days to 3,178 days"]
- + ["Company has delivered good sales growth of 16.3% CAGR over last 5 years"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.